MedTrace Logo

CAES for Internal Hemorrhoids and Rectal Prolapse

NCT04169152 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2024-04-02

No results posted yet for this study

Summary

Cap-assisted endoscopic sclerotherapy (CAES) is a new interventional therapy for internal hemorrhoids and rectal prolapse under colonoscopy. However, the long-term efficacy and safety of CAES in the treatment of internal hemorrhoids and rectal prolapse are still not clear due to the lack of large sample studies. Therefore, a nationwide multi-center, large sample, prospective and cohort study was designed to evaluate the efficacy and safety of CAES in the treatment of internal hemorrhoids and rectal prolapse, to provide reliable evidence for popularization of this minimally invasive technology.

Conditions

  • Internal Hemorrhoid
  • Rectal Prolapse

Interventions

PROCEDURE

Cap-assisted endoscopic sclerotherapy

Cap-assisted endoscopic sclerotherapy (CAES) is an innovation technique for having advantages in accurately controlling the injection angle, direction, depth under direct vision of flexible endoscope.

Sponsors & Collaborators

  • Faming Zhang

    lead OTHER

Principal Investigators

  • Faming Zhang, MD,PhD · The Second Hospital of Nanjing Medical University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-30
Primary Completion
2027-12-30
Completion
2028-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04169152 on ClinicalTrials.gov